We are IQVIA, The Human Data Science CompanyTM
Healthcare is an industry designed to help humans. As a global community, we continuously invest and commit to advancing human health. To deliver value and real outcomes. To rise to the challenge to find the next breakthrough by making the most of increasingly limited resources.
We are inspired by the potential and propelled by the possibilities. We share the vision to drive healthcare forward. To see how we can help accelerate progress and achievements. Others are developing these medical breakthroughs. We do our part by using breakthroughs in insights, technology and human intelligence to reimagine and deliver ways to help make them a reality.
It’s bigger than better clinical trials. Or advances in technologies and analytics. Or faster insights. It’s about unleashing the power of human data science. And that is why IMS Health and Quintiles have come together to be IQVIA, The Human Data Science Company.
Here in the UK, we serve top pharmaceutical companies and the majority of NHS Trusts, being firmly centered between healthcare and life sciences. What differentiates us is Institutional Knowledge, gained from being the UK’s leading clinical trial provider through partnerships with the NHS in three ‘prime sites’ covering a population of around 13 million people, and from our 250 London based Real-World Evidence experts. Our Advanced Technology platforms and capabilities allow us to provide real-time access to operations critical information for our customers. We have Unparalleled Data¸ with over 1 billion anonymised patient transactions every year. And finally, Advanced Analytics that underpin faster more precise decision-making, giving actionable insights into patient care and medicines usage. It is these CORE capabilities and our partnerships with the NHS and life sciences that are the catalyst to truly advance UK healthcare.
Motivated by the industry we help, we’re committed to providing solutions that enable life sciences companies to innovate with confidence, maximize opportunities, and, ultimately, drive human health outcomes forward.